Hugo Fuentes

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel

Priyanka Sharma, Sara López‐Tarruella, José Á. García-Sáenz et al. · Clinical Cancer Research · 2018 · 128 citations · Full text

Medicine, Oncology, Pharmacology +17

Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification

Isabel Echavarría, Sara López‐Tarruella, Antoni C. Picornell et al. · Clinical Cancer Research · 2018 · 114 citations · Full text

Medicine, Oncology, Pharmacology +17

Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Is Associated with Indigenous American Ancestry in Latin American Women

Katie M. Marker, Valentina A. Zavala, Tatiana Vidaurre et al. · Cancer Research · 2020 · 56 citations · Full text

Medicine, Genetics, Oncology +16

Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial

Milagros González‐Rivera, Miriam Lobo, Sara López‐Tarruella et al. · Breast Cancer Research and Treatment · 2016 · 41 citations

Medicine, Genetics, Oncology +17

Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer

Zaida Morante, Rossana Ruiz, Jhajaira M. Araujo et al. · Clinical Breast Cancer · 2020 · 29 citations · Full text

Medicine, Oncology, Breast Oncology +12